Genetic analysis explains rare disease severity, points to possible treatment
Researchers at WashU Medicine have uncovered why some patients with a rare genetic disorder called primary ciliary dyskinesia have worse lung problems than others with the same disorder.
Thomas receives lifetime achievement award
Lawrence E. Thomas, a member of the WashU Board of Trustees and an alumnus, was honored with a lifetime achievement award by the St. Louis American Foundation.
Compound harnesses cannabis’s pain-relieving properties without side effects
Researchers at WashU Medicine developed a compound, derived from cannabis, that relieves pain in mice but doesn’t affect the brain, thereby avoiding mind-altering side effects and abuse potential.
Jiang-Xie selected for WashU Medicine Bold Pioneer Award
Li-Feng Jiang-Xie, a postdoctoral research associate in the Department of Pathology and Immunology at WashU Medicine, has received the 2024 WashU Medicine Bold Pioneer Award.
Ahmad, Fraum named Loeb Teaching Fellows
Fahd A. Ahmad, MD, and Tyler Fraum, MD, have been selected as the 2025-27 Carol B. and Jerome T. Loeb Teaching Fellows at WashU Medicine.
Effort to solve medical mysteries extends to underserved communities
The Undiagnosed Diseases Network at WashU Medicine plans to increase outreach to medically underserved communities and boost the number of patients seen.
Study identifies brain cells key to understanding other people
Researchers at WashU Medicine Mallinckrodt Institute of Radiology have identified specific neuronal cells that are essential to our understanding of other people.
WashU Medicine launches center for rare diseases
WashU Medicine has launched the Center for Rare, Undiagnosed and Genetic Diseases, which brings together researchers and patient communities to create a collaborative network to drive innovative research and accelerate drug discovery.
Garcia to study protein arginylation
Benjamin Garcia, the Raymond H. Wittcoff Distinguished Professor at WashU Medicine, along with colleagues Zongtao (Tom) Lin and Dongwen Lyu, received a four-year $2.4 million grant renewal from the National Heart, Lung and Blood Institute, part of the National Institutes of Health (NIH).
Next-gen Alzheimer’s drugs extend independent living by months
An analysis by researchers at WashU Medicine interprets the benefits of new Alzheimer’s drugs in a way that aims to help patients and families make informed treatment decisions.
View More Stories